NewAmsterdam Pharma initiated with an Outperform at BMO Capital
Very bullish setup
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Very bullish setup
What happened, with direct paths to the underlying reporting
BMO Capital initiated coverage with Outperform; target price $58; current price $29.67.
Target: $58
Posted price: $29.67
Analyst firm: BMO Capital
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.